PTRH2 Inhibitors
PTRH2 inhibitors represent a class of compounds strategically designed to modulate PTRH2 activity through indirect mechanisms, primarily focusing on mitochondrial metabolism, mitochondrial dynamics, and energy-related signaling pathways. This intricate class of inhibitors exhibits a commonality in their ability to impact fundamental cellular processes by disrupting redox balance, mitochondrial function, and energy homeostasis. Among the selected inhibitors, mitochondrial complex I inhibitors, including IACS-010759, Phenformin, Metformin, Rotenone, Atpenin A5, and Rotenone Oxime, play a crucial role in disrupting electron transport within the mitochondria. This disruption, in turn, affects redox balance, creating a cascade of alterations in cellular processes dependent on proper mitochondrial function, ultimately influencing PTRH2 activity. The mitochondrial pyruvate carrier (MPC) inhibitor UK-5099 intervenes in pyruvate transport, thereby impacting mitochondrial function and, consequently, indirectly modulating PTRH2.
Additionally, Mdivi-1, acting as a mitochondrial fission inhibitor, contributes to the disruption of proper mitochondrial morphology. This interference influences redox balance and cellular processes that are intricately connected to mitochondrial dynamics, subsequently impacting PTRH2. Compounds like FCCP serve as mitochondrial uncouplers, disrupting the proton gradient and influencing redox balance, further implicating cellular processes dependent on proper mitochondrial function and indirectly affecting PTRH2. AICAR, an activator of AMPK, plays a pivotal role in influencing cellular energy balance, thereby indirectly modulating PTRH2 activity. GW501516, a PPAR-delta activator, exerts its effects on cellular metabolism, contributing to the indirect modulation of PTRH2. Iodoacetic Acid, a glycolytic inhibitor, disrupts the glycolytic pathway, impacting cellular energy metabolism and influencing PTRH2 indirectly. In conclusion, the diverse mechanisms of action among PTRH2 inhibitors underscore the intricate connections between mitochondrial function, cellular metabolism, and PTRH2 activity. This chemical class provides a nuanced understanding of the regulatory mechanisms of PTRH2, offering valuable insights into potential avenues for future research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phenformin Hydrochloride | 834-28-6 | sc-219590 | 10 g | $119.00 | 4 | |
Phenformin inhibits PTRH2 indirectly by influencing mitochondrial metabolism. As a mitochondrial complex I inhibitor, Phenformin disrupts electron transport, affecting redox balance. This indirect inhibition modulates cellular processes dependent on proper mitochondrial function, subsequently impacting PTRH2. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin inhibits PTRH2 indirectly by influencing mitochondrial metabolism. As a mitochondrial complex I inhibitor, Metformin disrupts electron transport, affecting redox balance. This indirect inhibition modulates cellular processes dependent on proper mitochondrial function, subsequently impacting PTRH2. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Rotenone inhibits PTRH2 indirectly by targeting mitochondrial metabolism. As a mitochondrial complex I inhibitor, Rotenone disrupts electron transport, impacting redox balance. This indirect inhibition modulates cellular processes dependent on proper mitochondrial function, subsequently affecting PTRH2. | ||||||
Atpenin A5 | 119509-24-9 | sc-202475 sc-202475A sc-202475B sc-202475C | 250 µg 1 mg 10 mg 50 mg | $195.00 $540.00 $2905.00 $12885.00 | 17 | |
Atpenin A5 inhibits PTRH2 indirectly by targeting mitochondrial metabolism. As a mitochondrial complex I inhibitor, Atpenin A5 disrupts electron transport, impacting redox balance. This indirect inhibition modulates cellular processes dependent on proper mitochondrial function, subsequently affecting PTRH2. | ||||||
UK 5099 | 56396-35-1 | sc-361394 sc-361394A | 10 mg 50 mg | $236.00 $987.00 | 5 | |
UK-5099 inhibits PTRH2 indirectly by targeting mitochondrial metabolism. As an inhibitor of the mitochondrial pyruvate carrier (MPC), UK-5099 disrupts pyruvate transport, influencing mitochondrial function. This indirect inhibition modulates cellular processes dependent on proper mitochondrial function, subsequently affecting PTRH2. | ||||||
Mdivi-1 | 338967-87-6 | sc-215291 sc-215291B sc-215291A sc-215291C | 5 mg 10 mg 25 mg 50 mg | $67.00 $126.00 $251.00 $465.00 | 13 | |
Mdivi-1 inhibits PTRH2 indirectly by targeting mitochondrial dynamics. As a mitochondrial fission inhibitor, Mdivi-1 disrupts proper mitochondrial morphology, influencing redox balance. This indirect inhibition modulates cellular processes dependent on mitochondrial dynamics, subsequently affecting PTRH2. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $94.00 $355.00 | 46 | |
FCCP inhibits PTRH2 indirectly by targeting mitochondrial uncoupling. As an uncoupler of oxidative phosphorylation, FCCP disrupts proton gradient, impacting redox balance. This indirect inhibition modulates cellular processes dependent on proper mitochondrial function, subsequently affecting PTRH2. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR inhibits PTRH2 indirectly by targeting AMP-activated protein kinase (AMPK). AICAR activates AMPK, influencing cellular energy balance. This indirect inhibition modulates cellular processes dependent on AMPK signaling, subsequently affecting PTRH2. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516 inhibits PTRH2 indirectly by targeting peroxisome proliferator-activated receptor-delta (PPAR-delta). GW501516 activates PPAR-delta, influencing cellular metabolism. This indirect inhibition modulates cellular processes dependent on PPAR-delta signaling, subsequently affecting PTRH2. | ||||||
Iodoacetic acid | 64-69-7 | sc-215183 sc-215183A | 10 g 25 g | $57.00 $99.00 | ||
Iodoacetic Acid inhibits PTRH2 indirectly by targeting glycolysis. As a glycolytic inhibitor, Iodoacetic Acid disrupts the glycolytic pathway, impacting cellular energy metabolism. This indirect inhibition modulates cellular processes dependent on glycolysis, subsequently affecting PTRH2. | ||||||